Connect with us
Merck, a science and technology company, announced its participation in a collaboration with the Vaccine Formulation Institute and the European...
Merck, a science and technology company, and the European Space Agency (ESA) signed a Letter of Intent to extend by a further two years their cooperation...
The newly appointed Supervisory Board of Merck KGaA re-elected Wolfgang Büchele as its Chairman at its constitutive meeting directly following the 24th Annual General Meeting. Michael...
Merck announced that data from across its multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology (AAN) 2019 Annual Meeting, 4–10 May...
Merck announced that data across several modalities and mechanisms targeting difficult-to-treat cancers will be presented at the 2019 American Society of Clinical Oncology (Asco) Annual Meeting,...
Merck, a science and technology company, announced that Susumu Kitagawa, Professor at the Institute for Integrated Cell–Material Sciences at Kyoto University, Japan, has been named the...
Merck, a science and technology company, held its 24th Annual General Meeting today at the Jahrhunderthalle in Frankfurt am Main. After Stefan Oschmann, Chairman of the...
Servier and Harvard researchers will embark on a three-year preclinical research project where the ultimate objective is to develop therapeutics targeting the microbiota for the treatment...
Sta Pharmaceutical Co., Ltd., (Wuxi Sta) – a subsidiary of Wuxi AppTec – and Beta Pharma, a biotech company focusing on innovative drug discovery and development...
At this year’s Interphex as well as at Powtech Coperion K-Tron will display the next generation of its highly accurate, gravimetric K3-PH feeders for the pharmaceutical...
